Department of Defense$1.8M obligationsEnds Jun 4, 2027
Federal contract award
W81XWH18C0170
IGF::OT::IGF HEMOPURE&BIOPLASMA FDP STUDIES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541713 — Research and Development in Nanotechnology |
| PSC | AN72 — SPECIALIZED MEDICAL SERVICES - APPLIED RESEARCH/EXPLORATORY DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIXED PRICE LEVEL OF EFFORT |
| Obligations | $8.2M |
| Current contract value | $8.2M |
| Potential contract value / ceiling | $8.2M |
| Start date | Sep 27, 2018 |
| Current end date | Dec 26, 2025 |
| Potential end date | Dec 26, 2025 |
| Latest award activity | Jun 10, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 10, 2025 | P00008 | $0 | HEMOPURE & BIOPLASMA STUDIES |
| Mar 11, 2025 | P00007 | $0 | HEMOPURE & BIOPLASMA STUDIES |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.